Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations

Abstract Orexins are hypothalamic neuropeptides primarily involved in regulating the sleep/wakefulness cycle and circadian rhythm. They bind to the orexin receptor type 1 (OX1) and type 2 (OX2), well-known drug targets in the treatment of sleep disorders, that have recently been shown to play a sign...

Full description

Saved in:
Bibliographic Details
Main Authors: Paulina Dragan, Valerie Gratio, Thierry Voisin, Alain Couvineau, Dorota Latek
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-03857-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849226414456307712
author Paulina Dragan
Valerie Gratio
Thierry Voisin
Alain Couvineau
Dorota Latek
author_facet Paulina Dragan
Valerie Gratio
Thierry Voisin
Alain Couvineau
Dorota Latek
author_sort Paulina Dragan
collection DOAJ
description Abstract Orexins are hypothalamic neuropeptides primarily involved in regulating the sleep/wakefulness cycle and circadian rhythm. They bind to the orexin receptor type 1 (OX1) and type 2 (OX2), well-known drug targets in the treatment of sleep disorders, that have recently been shown to play a significant role in different cancers. Lemborexant is one of a few orexin receptor antagonists that have been approved for the treatment of insomnia. Despite being classified as an antagonist, lemborexant may display agonist-like behavior in the non-canonical signaling pathway of the orexin receptors, as confirmed recently in cancer cell models. Here, we generated a model of OX2 in complex with the full-length Gq protein and used it in the molecular dynamics (MD) study. We compared the impact of lemborexant and the OX2-selective, potent agonist compound 1 on OX2 activation and subsequent guanosine diphosphate (GDP) to guanosine triphosphate (GTP) exchange in the Gαq subunit. These 2 µs MD simulations showed that both ligands evoke similar, activation-like conformational changes in OX2 and explained the observed lemborexant-mediated apoptosis of cancer cells. In addition, MD simulations of the active-state OX2-Gq complexes allowed us to uncover a sequence of micro- and macroscale events during the activation of Gq and to detect important micro- and macroswitches in the Gα subunit.
format Article
id doaj-art-3a1fb40771554a2ca7590820c77167d0
institution Kabale University
issn 2045-2322
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-3a1fb40771554a2ca7590820c77167d02025-08-24T11:20:48ZengNature PortfolioScientific Reports2045-23222025-08-0115111310.1038/s41598-025-03857-0Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulationsPaulina Dragan0Valerie Gratio1Thierry Voisin2Alain Couvineau3Dorota Latek4Faculty of Chemistry, University of WarsawINSERM UMR1149/Inflammation Research Center (CRI), Université Paris Cité, Team “From Inflammation to Cancer in Digestive Diseases (INDiD)”, DHU UNITYINSERM UMR1149/Inflammation Research Center (CRI), Université Paris Cité, Team “From Inflammation to Cancer in Digestive Diseases (INDiD)”, DHU UNITYINSERM UMR1149/Inflammation Research Center (CRI), Université Paris Cité, Team “From Inflammation to Cancer in Digestive Diseases (INDiD)”, DHU UNITYFaculty of Chemistry, University of WarsawAbstract Orexins are hypothalamic neuropeptides primarily involved in regulating the sleep/wakefulness cycle and circadian rhythm. They bind to the orexin receptor type 1 (OX1) and type 2 (OX2), well-known drug targets in the treatment of sleep disorders, that have recently been shown to play a significant role in different cancers. Lemborexant is one of a few orexin receptor antagonists that have been approved for the treatment of insomnia. Despite being classified as an antagonist, lemborexant may display agonist-like behavior in the non-canonical signaling pathway of the orexin receptors, as confirmed recently in cancer cell models. Here, we generated a model of OX2 in complex with the full-length Gq protein and used it in the molecular dynamics (MD) study. We compared the impact of lemborexant and the OX2-selective, potent agonist compound 1 on OX2 activation and subsequent guanosine diphosphate (GDP) to guanosine triphosphate (GTP) exchange in the Gαq subunit. These 2 µs MD simulations showed that both ligands evoke similar, activation-like conformational changes in OX2 and explained the observed lemborexant-mediated apoptosis of cancer cells. In addition, MD simulations of the active-state OX2-Gq complexes allowed us to uncover a sequence of micro- and macroscale events during the activation of Gq and to detect important micro- and macroswitches in the Gα subunit.https://doi.org/10.1038/s41598-025-03857-0Orexin receptorsOX2Gq protein activationGDP/GTP exchangeSignal transductionLemborexant
spellingShingle Paulina Dragan
Valerie Gratio
Thierry Voisin
Alain Couvineau
Dorota Latek
Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations
Scientific Reports
Orexin receptors
OX2
Gq protein activation
GDP/GTP exchange
Signal transduction
Lemborexant
title Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations
title_full Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations
title_fullStr Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations
title_full_unstemmed Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations
title_short Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations
title_sort non canonical gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations
topic Orexin receptors
OX2
Gq protein activation
GDP/GTP exchange
Signal transduction
Lemborexant
url https://doi.org/10.1038/s41598-025-03857-0
work_keys_str_mv AT paulinadragan noncanonicalgqactivationbyorexinreceptortype2andlemborexantobservedinmicrosecondmoleculardynamicssimulations
AT valeriegratio noncanonicalgqactivationbyorexinreceptortype2andlemborexantobservedinmicrosecondmoleculardynamicssimulations
AT thierryvoisin noncanonicalgqactivationbyorexinreceptortype2andlemborexantobservedinmicrosecondmoleculardynamicssimulations
AT alaincouvineau noncanonicalgqactivationbyorexinreceptortype2andlemborexantobservedinmicrosecondmoleculardynamicssimulations
AT dorotalatek noncanonicalgqactivationbyorexinreceptortype2andlemborexantobservedinmicrosecondmoleculardynamicssimulations